Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
We are advancing our commercial preparation activities in anticipation of a potential launch of OLC later this year, to help provide an important treatment option to patients with chronic kidney disease (CKD) on dialysis who continue to struggle with hyperphosphatemia. The NDA is supported by data from three clinical studies, multiple preclinical studies, and chemistry, manufacturing and controls (CMC) data
PMID: 24152852
Genetic variants in the GLP1R gene (such as rs6923761) are associated with differential GLP-1 receptor sensitivity and response patterns
Contraindications: Consult your doctor or pharmacist before use if you are pregnant or likely to become pregnant, breastfeeding, or have a predisposition to kidney stones formation or iron disorders
2:24-md-03094, 5/8/24.
US$ 25.00
US$ 23.89
US$ 26.56
US$ 24.29
US$ 21.73
